During the past decade, Desert Endocrinology Clinical Research Center conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 5 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Desert Endocrinology Clinical Research Center" #1 sponsor was "Boehringer Ingelheim" with 2 trials, followed by "Kowa Research Institute, Inc." with 2 trials sponsored, "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 2 trials sponsored, "DexCom, Inc." with 1 trials sponsored and "Diasome Pharmaceuticals" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Desert Endocrinology Clinical Research Center" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator and "Integrium" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Desert Endocrinology Clinical Research Center" are "Diabetes Mellitus, Type 1" (2 trials), "Severe Hypertriglyceridemia" (2 trials), "Diabetes Mellitus" (1 trials), "Diabetes Mellitus, Type 2" (1 trials) and "Diabetic Neuropathy, Painful" (1 trials). Many other conditions were trialed in "Desert Endocrinology Clinical Research Center" in a lesser frequency.

Most popular intervention types in "Desert Endocrinology Clinical Research Center" are "Drug" (9 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Empagliflozin" (2 trials), "Fenofibrate" (2 trials), "K-877" (2 trials) and "Placebo (for K-877)" (2 trials). Other intervention names were less common.

The vast majority of trials in "Desert Endocrinology Clinical Research Center" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Desert Endocrinology Clinical Research Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Desert Endocrinology Clinical Research Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Desert Endocrinology Clinical Research Center, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".